SalvaRx Group plc reported unaudited consolidated earnings results for the six months ended June 30, 2017. For the period, the company reported operating loss of £1,331,000 compared to £1,378,000 a year ago. Loss before tax was £1,403,000 compared to £1,403,000 a year ago. Net loss and comprehensive loss attributable to owners of the company was £1,091,000 or 0.03 pence per basic and diluted share compared to £1,388,000 or 0.05 pence per basic and diluted share a year ago. Net cash outflow from operating activities was £940,000 compared to £640,000 a year ago.